Rocket Pharmaceuticals Inc buy geldnutzer
Start price
16.09.24
/
60%
€18.02
Target price
16.09.25
€21.00
Performance (%)
8.94%
Price
17.09.24
?
Summary
This prediction is currently active. With a performance of 8.94%, the BUY prediction by geldnutzer for Rocket Pharmaceuticals Inc is trending in the right direction. This prediction currently runs until 16.09.25. The prediction end date can be changed by geldnutzer at any time. geldnutzer has 60% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Rocket Pharmaceuticals Inc | 8.94% |
| iShares Core DAX® | 1.887% |
| iShares Nasdaq 100 | 2.316% |
| iShares Nikkei 225® | 1.134% |
| iShares S&P 500 | 1.821% |
According to geldnutzer what are the pros and cons of Rocket Pharmaceuticals Inc for the foreseeable future?
Pros
Revenue growth >5% per year expected
Valuable balance sheet
Good culture
Top 10 in its market
Could be worthwhile Investment >10% per year
Growths faster than the competition
Stable Large shareholder and/or long term investor
EBIT growth >5% per year expected
positive Cash Flow expected
Standard Investments for future growth
Normal challenges to pay loans and raise capital
Capable Management
Innovative
Sustainability is important
Medium risks for its business
Future proof or reliable business model
Cons
Few uniques
Dependend from some customers or products
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
Significant cyclical dependencies
Little known brand
ROE lower than 10% per year